{"version":"1.0","type":"link","title":"A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies.","author_name":"He F 외","author_url":"https://prs-insight.online/author/He%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/164604","thumbnail_width":1200,"thumbnail_height":630}